|Bid||431.55 x 800|
|Ask||433.18 x 1400|
|Day's Range||417.41 - 436.56|
|52 Week Range||330.01 - 560.00|
|Beta (5Y Monthly)||0.49|
|PE Ratio (TTM)||22.24|
|Earnings Date||Apr 26, 2021 - Apr 30, 2021|
|Forward Dividend & Yield||1.36 (0.32%)|
|Ex-Dividend Date||Feb 26, 2021|
|1y Target Est||595.00|
Image source: The Motley Fool. Chemed Corp (NYSE: CHE)Q4 2020 Earnings CallFeb 24, 2021, 10:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, thank you for standing by, and welcome to the Chemed Corporation Fourth Quarter 2020 Earnings Conference Call.
Looking into the current session, Chemed Inc. (NYSE:CHE) is trading at $481.23, after a 0.11% decrease. Over the past month, the stock decreased by 7.30%, but over the past year, it actually spiked by 9.31%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. Assuming that all other factors are held constant, this could present itself as an opportunity for shareholders trying to capitalize on the higher share price. The stock is currently below from its 52 week high by 14.07%. The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E indicates that shareholders do not expect the stock to perform better in the future, and that the company is probably undervalued. It shows that shareholders are less than willing to pay a high share price, because they do not expect the company to exhibit growth, in terms of future earnings. View more earnings on CHE Depending on the particular phase of a business cycle, some industries will perform better than others. Chemed Inc. has a lower P/E than the aggregate P/E of 34.86 of the Health Care Providers & Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. There are many limitations to P/E ratio. It is sometimes difficult to determine the nature of the earnings makeup of a company. Shareholders might not get what they're looking for, from trailing earnings. See more from BenzingaClick here for options trades from BenzingaRecap: Chemed Q4 EarningsEarnings Scheduled For February 23, 2021© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
NEW YORK, NY / ACCESSWIRE / February 24, 2021 / Chemed Corp. (NYSE:CHE) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 24, 2021 at 10:00 AM Eastern Time.